Cargando…

A Novel Curcumin Analog (H-4073) Enhances the Therapeutic Efficacy of Cisplatin Treatment in Head and Neck Cancer

Chemotherapy constitutes the standard modality of treatment for localized head and neck squamous cell carcinomas (HNSCC). However, many patients fail to respond and relapse after this treatments due to the acquisition of chemo-resistance. Therefore, there is an urgent need to develop novel drugs tha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kumar, Bhavna, Yadav, Arti, Hideg, Kalman, Kuppusamy, Periannan, Teknos, Theodoros N., Kumar, Pawan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3968069/ https://www.ncbi.nlm.nih.gov/pubmed/24675768 http://dx.doi.org/10.1371/journal.pone.0093208

Ejemplares similares

Bazedoxifene enhances the anti-tumor effects of cisplatin and radiation treatment by blocking IL-6 signaling in head and neck cancer
por: Yadav, Arti, et al.
Publicado: (2016)

Dysregulation of MicroRNA-34a Expression in Head and Neck Squamous Cell Carcinoma Promotes Tumor Growth and Tumor Angiogenesis
por: Kumar, Bhavna, et al.
Publicado: (2012)

Suberoylanilide hydroxamic acid (SAHA) reverses chemoresistance in head and neck cancer cells by targeting cancer stem cells via the downregulation of nanog
por: Kumar, Bhavna, et al.
Publicado: (2015)

A muscle specific protein “myoferlin” modulates IL-6/STAT3 signaling by chaperoning activated STAT3 to nucleus
por: Yadav, Arti, et al.
Publicado: (2017)

Tetrathiomolybdate inhibits head and neck cancer metastasis by decreasing tumor cell motility, invasiveness and by promoting tumor cell anoikis
por: Kumar, Pawan, et al.
Publicado: (2010)

Tumor-Associated Endothelial Cells Promote Tumor Metastasis by Chaperoning Circulating Tumor Cells and Protecting Them from Anoikis
por: Yadav, Arti, et al.
Publicado: (2015)

Novel therapeutics and emerging technologies in head and neck cancer
por: Teknos, Theodoros N.
Publicado: (2016)

Interleukin-6 role in head and neck squamous cell carcinoma progression
por: Choudhary, Moaz M., et al.
Publicado: (2016)

Safe and targeted anticancer therapy for ovarian cancer using a novel class of curcumin analogs
por: Rath, Kellie S, et al.
Publicado: (2013)

ATN-224 enhances antitumor efficacy of oncolytic herpes virus against both local and metastatic head and neck squamous cell carcinoma
por: Yoo, Ji Young, et al.
Publicado: (2015)

Reolysin and Histone Deacetylase Inhibition in the Treatment of Head and Neck Squamous Cell Carcinoma
por: Jaime-Ramirez, Alena C., et al.
Publicado: (2017)

Nuclear PRMT5, cyclin D1 and IL-6 are associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with p16-status
por: Kumar, Bhavna, et al.
Publicado: (2017)

The Effect of Resveratrol or Curcumin on Head and Neck Cancer Cells Sensitivity to the Cytotoxic Effects of Cisplatin
por: Bostan, Marinela, et al.
Publicado: (2020)

The current status of oncolytic viral therapy for head and neck cancer
por: Old, Matthew O., et al.
Publicado: (2016)

4073 Parents of Faith Support School-Based Sex Education: A Louisiana Study
por: Boos, Elise Walsh, et al.
Publicado: (2020)

Molecular profiling of head and neck squamous cell carcinoma
por: Feldman, Rebecca, et al.
Publicado: (2015)

Hyperoxygenation as a Therapeutic Supplement for Treatment of Triple Negative Breast Cancer
por: Mast, Jesse M., et al.
Publicado: (2018)

RhoC Regulates Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma by Overexpressing IL-6 and Phosphorylation of STAT3
por: Islam, Mozaffarul, et al.
Publicado: (2014)

TriCurin, a novel formulation of curcumin, epicatechin gallate, and resveratrol, inhibits the tumorigenicity of human papillomavirus-positive head and neck squamous cell carcinoma
por: Piao, Longzhu, et al.
Publicado: (2016)

Prognostic Factors for the Therapeutic Performance of Cisplatin in Head and Neck Malignancies
por: Jungbauer, Frederic, et al.
Publicado: (2022)

Synergistic Effects of New Curcumin Analog (PAC) and Cisplatin on Oral Cancer Therapy
por: Semlali, Abdelhabib, et al.
Publicado: (2023)

Liposome encapsulated curcumin-difluorinated (CDF) inhibits the growth of cisplatin resistant head and neck cancer stem cells
por: Basak, Saroj K., et al.
Publicado: (2015)

Mitochondrial-Targeted Curcuminoids: A Strategy to Enhance Bioavailability and Anticancer Efficacy of Curcumin
por: Reddy, Cheruku Apoorva, et al.
Publicado: (2014)

Weak association between the interleukin-8 rs4073 polymorphism and acute pancreatitis: a cumulative meta-analysis
por: Li, Yening, et al.
Publicado: (2019)

Improving Therapeutic Ratio in Head and Neck Cancer with Adjuvant and Cisplatin-Based Treatments
por: Marcu, Loredana G.
Publicado: (2013)

Targeting constitutively-activated STAT3 in hypoxic ovarian cancer, using a novel STAT3 inhibitor
por: McCann, Georgia A., et al.
Publicado: (2014)

Curcumin as therapeutics for the treatment of head and neck squamous cell carcinoma by activating SIRT1
por: Hu, An, et al.
Publicado: (2015)

Identification of hub genes involved in cisplatin resistance in head and neck cancer
por: Chaudhary, Raushan Kumar, et al.
Publicado: (2023)

DEK associates with tumor stage and outcome in HPV16 positive oropharyngeal squamous cell carcinoma
por: Smith, Eric A., et al.
Publicado: (2017)

Interleukin-8 Gene −251 A/T (rs4073) Polymorphism and Coronary Artery Disease Risk: A Meta-Analysis
por: Zhang, Shunrong, et al.
Publicado: (2019)

Long term results of comparison of concurrent low-dose daily cisplatin versus the standard weekly cisplatin with six fractions per week radiotherapy in locally advanced head neck cancer
por: Gupta, Pramod Kumar, et al.
Publicado: (2016)

Curcumin and its Analogs and Carriers: Potential Therapeutic Strategies for Human Osteosarcoma
por: Lu, Ko-Hsiu, et al.
Publicado: (2023)

High expression of myoferlin is associated with poor outcome in oropharyngeal squamous cell carcinoma patients and is inversely associated with HPV-status
por: Kumar, Bhavna, et al.
Publicado: (2016)

NCX-4040, a nitric oxide-releasing aspirin, sensitizes drug-resistant human ovarian xenograft tumors to cisplatin by depletion of cellular thiols
por: Bratasz, Anna, et al.
Publicado: (2008)

Curcumin and Other Polyphenolic Compounds in Head and Neck Cancer Chemoprevention
por: Baumeister, Philipp, et al.
Publicado: (2012)

Curcumin: A review of anti-cancer properties and therapeutic activity in head and neck squamous cell carcinoma
por: Wilken, Reason, et al.
Publicado: (2011)

Chemoradiotherapy With Generic Cisplatin Formulations for Head and Neck Cancers
por: Shimada, Rie, et al.
Publicado: (2018)

The genetic variant rs4073 A→T of the Interleukin‐8 promoter region is associated with the earlier onset of exudative age‐related macular degeneration
por: Hautamäki, Asta, et al.
Publicado: (2015)

Genetic polymorphisms in interleukin-1β (rs1143634) and interleukin-8 (rs4073) are associated with survival after resection of intrahepatic cholangiocarcinoma
por: Lurje, Isabella, et al.
Publicado: (2023)

microRNA-107 functions as a candidate tumor suppressor gene in head and neck squamous cell carcinoma by down-regulation of protein kinase Cε
por: Datta, Jharna, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_p4fff2iugsmia7eftobeecou3d